173 related articles for article (PubMed ID: 23240674)
61. [A clinical analysis of 153 uterine sarcomas].
Bai P; Sun J; Chao H
Zhonghua Fu Chan Ke Za Zhi; 1997 Mar; 32(3):163-7. PubMed ID: 9596892
[TBL] [Abstract][Full Text] [Related]
62. Telomerase activity in needle biopsied uterine myoma-like tumors: differential diagnosis between uterine sarcomas and leiomyomas.
Tsujimura A; Kawamura N; Ichimura T; Honda K; Ishiko O; Ogita S
Int J Oncol; 2002 Feb; 20(2):361-5. PubMed ID: 11788902
[TBL] [Abstract][Full Text] [Related]
63. [Purely mesenchymal homologous uterus sarcomas (leiomyosarcomas and endometrial stroma sarcomas) at the Zurich University Gynecologic Hospital].
Bronz L; Genton CY; Kunz J; Schreiner WE
Geburtshilfe Frauenheilkd; 1985 May; 45(5):288-93. PubMed ID: 4007466
[TBL] [Abstract][Full Text] [Related]
64. [Myxoid mesenchymal tumors of uterus: endometrial stromal and smooth muscle tumors, myxoid variant].
Chesnais AL; Watkin E; Beurton D; Devouassoux-Shisheboran M
Ann Pathol; 2011 Jun; 31(3):152-8. PubMed ID: 21736994
[TBL] [Abstract][Full Text] [Related]
65. Recent advances in the histological and molecular classification of endometrial stromal neoplasms.
Ferreira J; Félix A; Lennerz JK; Oliva E
Virchows Arch; 2018 Dec; 473(6):665-678. PubMed ID: 30324234
[TBL] [Abstract][Full Text] [Related]
66. A prognosis based classification of undifferentiated uterine sarcomas: identification of mitotic index, hormone receptors and YWHAE-FAM22 translocation status as predictors of survival.
Gremel G; Liew M; Hamzei F; Hardell E; Selling J; Ghaderi M; Stemme S; Pontén F; Carlson JW
Int J Cancer; 2015 Apr; 136(7):1608-18. PubMed ID: 25130488
[TBL] [Abstract][Full Text] [Related]
67. Gene expression signatures differentiate uterine endometrial stromal sarcoma from leiomyosarcoma.
Davidson B; Abeler VM; Hellesylt E; Holth A; Shih IeM; Skeie-Jensen T; Chen L; Yang Y; Wang TL
Gynecol Oncol; 2013 Feb; 128(2):349-55. PubMed ID: 23178314
[TBL] [Abstract][Full Text] [Related]
68. Gastrointestinal stromal tumours: a case report and recent concepts.
Shojaie M; Abbas Z; Sultan N; Kazi J
J Pak Med Assoc; 2004 May; 54(5):278-80. PubMed ID: 15270191
[No Abstract] [Full Text] [Related]
69. Uterine Mesenchymal Tumors: Update on Classification, Staging, and Molecular Features.
Parra-Herran C; Howitt BE
Surg Pathol Clin; 2019 Jun; 12(2):363-396. PubMed ID: 31097109
[TBL] [Abstract][Full Text] [Related]
70. [Uterine leiomyosarcoma: epidemiology, pathology, biology, diagnosis, prognosis and treatment].
Hadoux J; Morice P; Lhommé C; Duvillard P; Balleyguier C; Haie-Meder C; Gouy S; Uzan C; Mazeron R; Tazi Y; Leary A; Duffaud F; Pautier P
Bull Cancer; 2013 Sep; 100(9):903-15. PubMed ID: 24004576
[TBL] [Abstract][Full Text] [Related]
71. Uterine sarcomas. Classification, diagnosis, and prognosis.
Kempson RL; Bari W
Hum Pathol; 1970 Sep; 1(3):331-49. PubMed ID: 4330001
[No Abstract] [Full Text] [Related]
72. Endometrial stromal nodule with smooth muscle differentiation.
Geetha V; Rupashree S; Bhat SS
Indian J Pathol Microbiol; 2008; 51(1):76-7. PubMed ID: 18417866
[TBL] [Abstract][Full Text] [Related]
73. Integrative Genomic and Transcriptomic Profiling Reveals a Differential Molecular Signature in Uterine Leiomyoma versus Leiomyosarcoma.
Machado-Lopez A; Alonso R; Lago V; Jimenez-Almazan J; Garcia M; Monleon J; Lopez S; Barcelo F; Torroba A; Ortiz S; Domingo S; Simon C; Mas A
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216305
[TBL] [Abstract][Full Text] [Related]
74. Diagnostic use of immunohistochemistry in uterine mesenchymal tumors.
D'Angelo E; Prat J
Semin Diagn Pathol; 2014 May; 31(3):216-22. PubMed ID: 24863031
[TBL] [Abstract][Full Text] [Related]
75. Molecular differential diagnosis of uterine leiomyomas and leiomyosarcomas.
Mas A; Simón C
Biol Reprod; 2019 Dec; 101(6):1115-1123. PubMed ID: 30184111
[TBL] [Abstract][Full Text] [Related]
76. Recently described entities in the gynaecological tract.
Reyes MC; Cooper K
Pathology; 2015 Aug; 47(5):414-22. PubMed ID: 26126047
[TBL] [Abstract][Full Text] [Related]
77. Metastatic uterine leiomyosarcoma with MDM2 amplification mimicking dedifferentiated liposarcoma: a diagnostic pitfall.
Agaimy A; Frohnauer J
Int J Gynecol Pathol; 2015 Mar; 34(2):177-9. PubMed ID: 25675188
[No Abstract] [Full Text] [Related]
78. Novel Therapeutics in the Treatment of Uterine Sarcoma.
Bose S; Schwartz GK; Ingham M
Am Soc Clin Oncol Educ Book; 2022 Apr; 42():900-909. PubMed ID: 35714303
[TBL] [Abstract][Full Text] [Related]
79. Diagnostic and prognostic morphometric features in WHO2003 invasive endometrial stromal tumours.
Feng W; Malpica A; Yinhua Y; Janssen E; Gudlaugsson E; Zhou X; Baak JP
Histopathology; 2013 Apr; 62(5):688-94. PubMed ID: 23530584
[TBL] [Abstract][Full Text] [Related]
80. Malignant tumors of the uterine corpus: molecular background of their origin.
Brany D; Dvorska D; Nachajova M; Slavik P; Burjanivova T
Tumour Biol; 2015 Sep; 36(9):6615-21. PubMed ID: 26307392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
